{"id":"sultamicillin","rwe":[{"pmid":"40678415","year":"2025","title":"FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.","finding":"","journal":"Turkish journal of biology = Turk biyoloji dergisi","studyType":"Clinical Study"},{"pmid":"40674823","year":"2025","title":"Indications and prescriptions of penicillins in a population of Colombia: A cross-sectional study.","finding":"","journal":"The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases","studyType":"Clinical Study"},{"pmid":"38334389","year":"2024","title":"Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses.","finding":"","journal":"The Journal of antimicrobial chemotherapy","studyType":"Clinical Study"},{"pmid":"37405113","year":"2023","title":"In Silico Studies of Indole Derivatives as Antibacterial Agents.","finding":"","journal":"Journal of pharmacopuncture","studyType":"Clinical Study"},{"pmid":"36861310","year":"2022","title":"Ternary system of sultamicillin tosylate with hydroxypropyl-β-cyclodextrin and L-arginine: susceptibility against methicillin-resistant Staphylococcus aureus.","finding":"","journal":"Therapeutic delivery","studyType":"Clinical Study"}],"tags":[{"label":"sultamicillin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"J01CR04","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"}],"phase":"discontinued","safety":{"safetySignals":[{"llr":61.754,"date":"","count":7,"signal":"Autoimmune dermatitis","source":"DrugCentral FAERS","actionTaken":"Reported 7 times (LLR=62)"}],"commonSideEffects":[{"effect":"Autoimmune dermatitis","drugRate":"LLR 62","severity":"common"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["sultamicillin","sultamicillin tosilate"],"offLabel":[],"synonyms":["sultamicillin","sultamicillin tosilate"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"sultamicillin","explanation":"Imagine your body's cells are like buildings, and bacteria are like construction workers. Sultamicillin stops the construction workers from building new walls, causing the bacteria to die. This is because sultamicillin blocks the enzymes that help bacteria build their cell walls.","oneSentence":"Sultamicillin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.","technicalDetail":"Sultamicillin exerts its antibacterial effect by inhibiting the enzyme transpeptidase, which is essential for bacterial cell wall synthesis, thereby preventing the formation of cross-links between peptidoglycan chains and ultimately leading to bacterial cell lysis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2539","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SULTAMICILLIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SULTAMICILLIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:46:42.608534","biosimilars":[],"competitors":[{"drugName":"ampicillin","drugSlug":"ampicillin","fdaApproval":"1965-12-17","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"amoxicillin","drugSlug":"amoxicillin","fdaApproval":"1974-12-09","patentExpiry":"May 7, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ticarcillin","drugSlug":"ticarcillin","fdaApproval":"1976-11-09","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"piperacillin","drugSlug":"piperacillin","fdaApproval":"1981-12-29","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"sultamicillin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ampicillin","brandName":"ampicillin","genericName":"ampicillin","approvalYear":"1965","relationship":"same-class"},{"drugId":"amoxicillin","brandName":"amoxicillin","genericName":"amoxicillin","approvalYear":"1974","relationship":"same-class"},{"drugId":"ticarcillin","brandName":"ticarcillin","genericName":"ticarcillin","approvalYear":"1976","relationship":"same-class"},{"drugId":"piperacillin","brandName":"piperacillin","genericName":"piperacillin","approvalYear":"1981","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":["Community Acquired Pneumonia in Children"],"enrollment":236,"completionDate":"2028-05"},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":["Pneumonia","Pneumonia in Children"],"enrollment":330,"completionDate":"2027-12-30"},{"nctId":"NCT06336213","phase":"NA","title":"Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients","status":"RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2024-01-23","conditions":["Aortic Aneurysm and Dissection","Cardiac Valve Disease","Thoracic Aortic Aneurysm","Thoracic Aortic Dissection"],"enrollment":50,"completionDate":"2027-02-15"},{"nctId":"NCT06440304","phase":"PHASE4","title":"Therapeutic Options for CRAB","status":"RECRUITING","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2025-01-30","conditions":["Infections, Bacterial","Sepsis Bacterial"],"enrollment":108,"completionDate":"2027-02"},{"nctId":"NCT07326540","phase":"PHASE3","title":"Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex","status":"NOT_YET_RECRUITING","sponsor":"BioVersys SAS","startDate":"2026-03-20","conditions":["Hospital Acquired Bacterial Pneumonia (HABP)","Ventilator Associated Bacterial Pneumonia (VABP)","Colistin Resistanrt ABC","Acinetobacter Baumannii-calcoaceticus Complex"],"enrollment":248,"completionDate":"2028-03-30"},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":["E Coli Infection","ESBL Producing E.Coli"],"enrollment":84,"completionDate":"2028-08"},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":["Community-acquired Pneumonia"],"enrollment":330,"completionDate":"2026-07-30"},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":["Preterm Premature Rupture of Membranes (PPROM)","Prophylaxis","Perinatal Outcomes"],"enrollment":40,"completionDate":"2025-08-10"},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":["Endovascular Infection","Bone and Joint Infection","Skin and Soft Tissue Infection","Pulmonary Infection","Gastrointestinal Infection","Genitourinary Infection"],"enrollment":94,"completionDate":"2025-02-14"},{"nctId":"NCT07118384","phase":"NA","title":"Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-05-01","conditions":["Acinetobacter Baumannii Infection"],"enrollment":50,"completionDate":"2026-01"},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":["Preterm Premature Rupture of Membranes (PPROM)"],"enrollment":138,"completionDate":"2028-05-01"},{"nctId":"NCT05922124","phase":"PHASE4","title":"Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2024-09-01","conditions":["Carbapenem Resistant Bacterial Infection","Acinetobacter Bacteremia","Acinetobacter Pneumonia"],"enrollment":734,"completionDate":"2026-09"},{"nctId":"NCT04198129","phase":"PHASE1","title":"The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-10-01","conditions":["Jaw Fractures","Infection"],"enrollment":13,"completionDate":"2022-03-20"},{"nctId":"NCT01463540","phase":"PHASE4","title":"Gastrostomy Tube Placed After Gastropexy Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2010-09","conditions":["Gastrostomy, Methods"],"enrollment":206,"completionDate":"2014-05"},{"nctId":"NCT06448624","phase":"PHASE4","title":"Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2024-04-01","conditions":["Heart Block","CIED Related Infection","CIED-related Infections","Antibiotic Prophylaxis","Biomarkers"],"enrollment":60,"completionDate":"2025-01-31"},{"nctId":"NCT06735703","phase":"","title":"Group B Streptococcus Infection and PROM Incidince","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-25","conditions":["Premature Rupture of Fetal Membranes","Group B Streptococcal Infection"],"enrollment":150,"completionDate":"2026-01-09"},{"nctId":"NCT04724044","phase":"PHASE3","title":"Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-01-25","conditions":["Community-acquired Pneumonia","Sepsis","Inflammatory Response","Mortality","Biomarkers","SIRS"],"enrollment":278,"completionDate":"2023-04-11"},{"nctId":"NCT06048692","phase":"PHASE3","title":"Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-01-01","conditions":["Cesarean Section; Infection"],"enrollment":213,"completionDate":"2023-09-20"},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"},{"nctId":"NCT04290104","phase":"PHASE4","title":"Is an Antibiotic Prescription Required After Laparoscopic Cholecystectomy","status":"UNKNOWN","sponsor":"Konya Meram State Hospital","startDate":"2020-10-15","conditions":["Cholecystitis; Acute, With Cholelithiasis"],"enrollment":2,"completionDate":"2020-12-31"},{"nctId":"NCT03560232","phase":"PHASE4","title":"Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens","status":"TERMINATED","sponsor":"Mercy Health Ohio","startDate":"2018-07-09","conditions":["Open Fracture","Post-Op Wound Infection"],"enrollment":17,"completionDate":"2020-02-19"},{"nctId":"NCT01892488","phase":"PHASE4","title":"Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2013-06-07","conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"enrollment":295,"completionDate":"2019-06-05"},{"nctId":"NCT01888822","phase":"PHASE4","title":"Antibiotic Prophylaxis in Laparoscopic Cholecystectomy","status":"TERMINATED","sponsor":"University of Roma La Sapienza","startDate":"2013-06","conditions":["Cholelithiasis"],"enrollment":138,"completionDate":"2017-06"},{"nctId":"NCT00879190","phase":"PHASE2,PHASE3","title":"Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-05","conditions":["Chorioamnionitis"],"enrollment":92,"completionDate":"2012-06"},{"nctId":"NCT00760006","phase":"PHASE2","title":"Preventing Complications in Cleft Palate Repair With Antibiotics","status":"COMPLETED","sponsor":"Joseph Losee","startDate":"2008-05","conditions":["Cleft Palates"],"enrollment":224,"completionDate":"2015-08"},{"nctId":"NCT02007603","phase":"PHASE3","title":"Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2013-08","conditions":["Infection During Hemodialysis"],"enrollment":16,"completionDate":"2017-05"},{"nctId":"NCT01118403","phase":"PHASE4","title":"Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients","status":"WITHDRAWN","sponsor":"Hospital Pablo Tobón Uribe","startDate":"2011-03","conditions":["Ventilator Associated Pneumonia"],"enrollment":0,"completionDate":"2011-03"},{"nctId":"NCT00619580","phase":"","title":"Ampicillin-sulbactam Resistant E.Coli at UPMC","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2008-02","conditions":["Positive E Coli Infections"],"enrollment":0,"completionDate":"2014-12"},{"nctId":"NCT00044746","phase":"PHASE4","title":"Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2000-10","conditions":["Diabetes Mellitus","Diabetic Foot"],"enrollment":314,"completionDate":"2003-01"},{"nctId":"NCT00356148","phase":"PHASE4","title":"The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.","status":"COMPLETED","sponsor":"Marmara University","startDate":"2003-10","conditions":["Breast Cancer"],"enrollment":372,"completionDate":"2010-05"},{"nctId":"NCT00368537","phase":"PHASE4","title":"Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-09","conditions":["Skin Diseases, Bacterial"],"enrollment":550,"completionDate":"2008-09"},{"nctId":"NCT01349738","phase":"","title":"Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants","status":"UNKNOWN","sponsor":"Rice, James C., M.D.","startDate":"2011-05","conditions":["Bacteriuria","Urinary Tract Infections","Asymptomatic Infections","Transplantation Infection"],"enrollment":200,"completionDate":"2013-05"},{"nctId":"NCT00630513","phase":"PHASE4","title":"T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam","status":"COMPLETED","sponsor":"University of Bologna","startDate":"2008-01","conditions":["Intra-Abdominal Infection"],"enrollment":142,"completionDate":"2010-12"},{"nctId":"NCT00952796","phase":"PHASE4","title":"A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2009-01","conditions":["Intra-abdominal Infection"],"enrollment":100,"completionDate":"2010-12"},{"nctId":"NCT00137007","phase":"PHASE4","title":"Zithromax EV in Community-Acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-11","conditions":["Pneumonia"],"enrollment":151,"completionDate":"2005-09"},{"nctId":"NCT01138852","phase":"PHASE4","title":"Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section","status":"COMPLETED","sponsor":"Attikon Hospital","startDate":"2004-07","conditions":["Surgical Site Infections"],"enrollment":176,"completionDate":"2008-12"},{"nctId":"NCT01045902","phase":"PHASE3","title":"BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2001-02","conditions":["Pneumonia, Aspiration","Lung Abscess"],"enrollment":139,"completionDate":"2005-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000021139","MMSL":"43062","NDDF":"005765","UNII":"65DT0ML581","VUID":"4023134","CHEBI":"CHEBI:51770","VANDF":"4023134","INN_ID":"5151","RXNORM":"1009148","UMLSCUI":"C2930041","ChEMBL_ID":"CHEMBL506110","KEGG_DRUG":"D05972","DRUGBANK_ID":"DB12127","PUBCHEM_CID":"444022","SNOMEDCT_US":"398786001","IUPHAR_LIGAND_ID":"12290","MESH_SUPPLEMENTAL_RECORD_UI":"C035444"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01CR04","allCodes":["J01CR04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025","pmid":"40678415","title":"FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.","journal":"Turkish journal of biology = Turk biyoloji dergisi"},{"date":"2025 Sep-Oct","pmid":"40674823","title":"Indications and prescriptions of penicillins in a population of Colombia: A cross-sectional study.","journal":"The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases"},{"date":"2024 Apr 2","pmid":"38334389","title":"Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses.","journal":"The Journal of antimicrobial chemotherapy"},{"date":"2023 Jun 30","pmid":"37405113","title":"In Silico Studies of Indole Derivatives as Antibacterial Agents.","journal":"Journal of pharmacopuncture"},{"date":"2022 Dec","pmid":"36861310","title":"Ternary system of sultamicillin tosylate with hydroxypropyl-β-cyclodextrin and L-arginine: susceptibility against methicillin-resistant Staphylococcus aureus.","journal":"Therapeutic delivery"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"discontinued","brandName":"SULTAMICILLIN","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sultamicillin is a small molecule antibiotic in the sultamicillin class, originally developed by an unknown entity. Its current owner is also unknown. The exact target of sultamicillin is not specified, but it is used to treat various bacterial infections. The commercial status of sultamicillin is unclear, with unknown patent status and generic manufacturers. Key safety considerations are also unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}